Hims & Hers CEO rejects FTC allegations regarding health data privacy

Hims & Hers CEO Andrew Dudum has publicly rejected allegations made by the U.S. Federal Trade Commission (FTC), characterizing the legal action as a misunderstanding of how the company is modernizing healthcare through a digital ecosystem.

The FTC, along with authorities in Los Angeles County and Utah, filed a lawsuit alleging that the company shared sensitive user health data with advertising partners, including Meta and Snap, without sufficient consent. Additional allegations include charging customers for prescriptions before medical consultations occurred and making it difficult for users to cancel subscriptions.

Dudum defended the company's business model as a necessary disruption of traditional healthcare structures. He suggested the FTC may be prioritizing headlines over reaching a genuine settlement. The company's stock has experienced volatility following the legal developments, and the matter is expected to be resolved in court.